Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Scrip Asia 100 - Our selected marketing/distribution player

This article was originally published in Scrip

Executive Summary

Zuellig Pharma began its services as a healthcare distribution specialist in Asia more than 60 years ago. Although headquartered in Hong Kong, the company has offices across 15 Asian countries and around 10,000 employees. Zuellig is an investor in Invida, a commercialisation services company also featured in the Scrip Asia 100 list of influential organisations.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC009324

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel